Page 32 - Stock Market Trading

SBI Cards and Payment Services tanks 7 per cent on muted Q2 earnings

SBI Card reported a modest quarter with net earnings impacted due to higher provisions.

Uncertainty on revenue growth, margin outlook hits Gland Pharma stock

The injectable manufacturing company expects the margin pressure to persist due to cost pressures and negative operating leverage.

F&O expiry: Sensex rises 213 pts, Nifty holds 17,750; metals rally, IT slip

CLOSING BELL: Tata Steel, Power Grid, Sun Pharma, Axis Bank, Bharti Airtel, Kotak Bank, M&M, HDFC, Dr Reddy's Labs, and Titan were the leading winners

Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin contracted 150 bps to 33 per cent from 38 per cent in a year ago quarter.

PNB, BHEL, IDFC among top mid-, smallcap stocks that can rally up to 25%

Technically, whenever any stock remains unaffected during times of volatility, the trend indicates something positive underneath. Such stocks are preferred by market participants for trading gains.

Analysts positive on Bank Nifty, advise picking up stocks on dips

Bank Nifty index has been outperforming the benchmark Nifty. It has gained 4% in the past one month and 16% YTD. In comparison, Nifty is up less than 2% both on a one-month and YTD basis

Global Health Limited's IPO to open on November 3: Red Herring Prospectus

The initial share sale of Global Health Limited, which operates and manages hospitals under the Medanta brand, will open for public subscription on November 3. The Initial Public Offering (IPO) will conclude on November 7, according to the Red Herring Prospectus (RHP). The IPO consists of a fresh issue of equity shares aggregating to Rs 500 crore and an offer for sale of up to 5.08 crore equity shares. As a part of the OFS, Anant Investments, an affiliate of private equity major Carlyle Group and Sunil Sachdeva (jointly with Suman Sachdeva), will offload equity shares. At present, Anant Investments holds 25.67 per cent shareholding in Global Health and Sachdeva owns 13.43 per cent stake in the company. Proceeds from the fresh issue will be used to pay debt and general corporate purposes. Founded by Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, Global Health is a leading private multi-speciality tertiary care providers in the North and East regions of ...

Debt MFs face lower risk, may put up a better show in Samvat 2079

Analysts advice investors to stay away from longer-duration funds yet, or consider a staggered plan

Uncertain outlook: Markets in Samvat 2079

With corporations still complaining about margin pressures and soft demand, markets will hope for broadening of recovery

Samvat 2078: A year of India's stock market outperformance to global peers

During the year, India's dematerialised account tally topped 100 million for the first time

Indian markets set to post worst Samvat show in 7 yrs; smallcaps outperform

FPIs offloaded nearly Rs 2 trillion ($265 billion) in Indian equities during Samvat 2078, data show.

Axis Bank Q2: Analysts see up to 28% upside on sustained earnings growth

Axis Bank shares hit a record high of Rs 905 on the BSE on Friday, surging 9.5 per cent in the intra-day trade, after the bank beat Street's September quarter earnings' expectations across parameters

Markets end marginally up on Friday; Sensex, Nifty down 1% in Samvat 2078

The BSE MidCap index fell about 4 per cent in Samvat 2078, while the BSE SmallCap index added 0.4 per cent

More companies will have to focus on profitability in future: Nikhil Kamath

If interest rates continue at their current trajectory, the appetite will go down, impacting the consumption and the markets, co-founder of Zerodha and True Beacon said

ITC hits new high on solid Q2 performance; analysts see up to 16% upside

Analysts believe ITC would continue to grow in its core business of Cigarettes and FMCG with stable taxation & softening of raw material prices.

F&O Strategy: Nandish Shah recommends Bull Spread Strategy on HCL Tech

The derivative analyst from HDFC Securities recommends buying HCL Technologies 1020 Call and selling 1040 Call of the October series.

ITC Q2 net profit rises 24% to Rs 4,619.77 crore; revenue up 24.4%

The company attributed the performance to strong and broad-based growth across markets and channels

Bajaj Finance Q2 results: Net profit jumps 88% to Rs 2,781 crore

The company booked 6.76 million loans in Q2FY23, up 7 per cent YoY compared to 6.33 million loans booked in the year-ago period

Asian Paints Q2 results: Net profit rises 31% to Rs 783 cr, sales up 18.8%

The initial capacity to be set up would be 265,000 tonnes per annum. In addition, clinker grinding would be set up in India as well

Sensex rises 96 pts after range-bound trade; Pvt banks weak, IT strong

CLOSING BELL: Meanwhile, the rupee will fall further against the US dollar over the rest of the year, a Reuters poll showed. It slipped to a record low of 83.21 today, and ended at 82.75/$